Detalhe da pesquisa
1.
A mouse model featuring tissue-specific deletion of p53 and Brca1 gives rise to mammary tumors with genomic and transcriptomic similarities to human basal-like breast cancer.
Breast Cancer Res Treat
; 174(1): 143-155, 2019 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-30484104
2.
Amplification of SOX4 promotes PI3K/Akt signaling in human breast cancer.
Breast Cancer Res Treat
; 162(3): 439-450, 2017 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28176176
3.
Activating PIK3CA Mutations Induce an Epidermal Growth Factor Receptor (EGFR)/Extracellular Signal-regulated Kinase (ERK) Paracrine Signaling Axis in Basal-like Breast Cancer.
Mol Cell Proteomics
; 14(7): 1959-76, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-25953087
4.
Cross-species DNA copy number analyses identifies multiple 1q21-q23 subtype-specific driver genes for breast cancer.
Breast Cancer Res Treat
; 152(2): 347-56, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-26109346
5.
SynthEx: a synthetic-normal-based DNA sequencing tool for copy number alteration detection and tumor heterogeneity profiling.
Genome Biol
; 18(1): 66, 2017 04 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-28390427
6.
Comprehensive analysis of The Cancer Genome Atlas reveals a unique gene and non-coding RNA signature of fibrolamellar carcinoma.
Sci Rep
; 7: 44653, 2017 03 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-28304380
7.
Characterization of copy number alterations in a mouse model of fibrosis-associated hepatocellular carcinoma reveals concordance with human disease.
Cancer Med
; 5(3): 574-85, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26778414
8.
An integrated genomics approach identifies drivers of proliferation in luminal-subtype human breast cancer.
Nat Genet
; 46(10): 1051-9, 2014 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-25151356
9.
Loss of heterozygosity at the CYP2D6 locus in breast cancer: implications for germline pharmacogenetic studies.
J Natl Cancer Inst
; 107(2)2014 Dec 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-25490892